“…There was also little variation in contraceptive failure, stratified by BMI and progesterone type for desogestrel, dienogest, drospirenone and levonorgestrel [73]. The only exception to this was a significant association of contraceptive failure in chlormadinone acetate-containing COC, which is highly lipophilic, among women with a high BMI (≥30 kg/m 2 ; p = 0.028) [73]. The average BMI of women enrolled in the EURAS-OC study was 22.1 ± 4.1 kg/m 2 compared with 26.3 ± 7.3 kg/m 2 in the US arm of the INAS-OC study [72,73].…”